Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients-Reference-Cited by-同舟云学术

Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients

Published:2022-12-02 Issue:3 Volume:4 Page:314-321
ISSN:2688-4526
Container-title:BJUI Compass
language:en
Short-container-title:BJUI Compass

Author:

Conroy Samantha¹²^ORCID,Pang Karl¹,Jubber Ibrahim¹²^ORCID,Hussain Syed A.³,Rosario Derek J.²,Cumberbatch Marcus G.¹²,Catto James W. F.¹²,Noon Aidan P.²

Affiliation:

1. Academic Urology Unit, Department of Oncology and Metabolism University of Sheffield Sheffield UK

2. Department of Urology Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK

3. Academic Oncology Unit, Department of Oncology and Metabolism University of Sheffield Sheffield UK

Publisher

Wiley

Subject

Religious studies,Cultural Studies

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bco2.203

Reference30 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018

3. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

4. Economic Burden of Bladder Cancer Across the European Union

5. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of conduction hyperthermia in the treatment of non-muscle invasive bladder cancer: A systematic review;Urologic Oncology: Seminars and Original Investigations;2024-09

2. Perfusion drugs for non‑muscle invasive bladder cancer (Review);Oncology Letters;2024-04-15

3. Validation of hyperthermia as an enhancer of chemotherapeutic efficacy: insights from a bladder cancer organoid model;International Journal of Hyperthermia;2024-02-12

4. Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study;International Urology and Nephrology;2024-02-08

5. Adjuvant Hyperthermic Intravesical Chemotherapy in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer;Cureus;2023-09-21